1.26
price up icon1.61%   0.02
pre-market  Pre-mercato:  1.26  
loading
Precedente Chiudi:
$1.24
Aprire:
$1.27
Volume 24 ore:
2.64M
Relative Volume:
0.61
Capitalizzazione di mercato:
$1.08B
Reddito:
$711.41M
Utile/perdita netta:
$-133.73M
Rapporto P/E:
-6.6316
EPS:
-0.19
Flusso di cassa netto:
$-199.99M
1 W Prestazione:
-7.35%
1M Prestazione:
-10.95%
6M Prestazione:
-21.74%
1 anno Prestazione:
-1.56%
Intervallo 1D:
Value
$1.25
$1.28
Intervallo di 1 settimana:
Value
$1.21
$1.355
Portata 52W:
Value
$1.19
$2.035

Opko Health Inc Stock (OPK) Company Profile

Name
Nome
Opko Health Inc
Name
Telefono
305-575-4181
Name
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Name
Dipendente
2,997
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
OPK's Discussions on Twitter

Confronta OPK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
OPK
Opko Health Inc
1.26 1.08B 711.41M -133.73M -199.99M -0.19
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
432.59 159.40B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
200.83 141.27B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
509.53 38.21B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
115.55 30.90B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
156.13 26.35B 15.50B 1.33B 2.16B 7.34

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-25 Iniziato JP Morgan Neutral
2023-06-29 Aggiornamento Barrington Research Mkt Perform → Outperform
2022-12-15 Iniziato H.C. Wainwright Buy
2022-01-24 Downgrade Barrington Research Outperform → Mkt Perform
2021-06-21 Iniziato Ladenburg Thalmann Buy
2019-11-25 Iniziato Piper Jaffray Overweight
2018-03-02 Downgrade JP Morgan Neutral → Underweight
2017-09-14 Downgrade JP Morgan Overweight → Neutral
2016-06-21 Reiterato Standpoint Research Buy
2016-06-03 Iniziato Standpoint Research Buy
2016-03-31 Reiterato Barrington Research Outperform
2015-10-16 Iniziato JP Morgan Overweight
2015-09-11 Downgrade Jefferies Buy → Hold
2015-03-03 Downgrade Oppenheimer Outperform → Perform
2014-05-12 Reiterato Oppenheimer Outperform
2014-03-14 Iniziato Oppenheimer Outperform
2013-11-13 Reiterato Ladenburg Thalmann Buy
2013-05-30 Reiterato Ladenburg Thalmann Buy
2012-10-22 Iniziato Barrington Research Outperform
2011-12-01 Reiterato Ladenburg Thalmann Buy
2011-07-14 Iniziato Ladenburg Thalmann Buy
Mostra tutto

Opko Health Inc Borsa (OPK) Ultime notizie

pulisher
12:33 PM

Renaissance Technologies LLC Sells 312,950 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

12:33 PM
pulisher
May 11, 2025

Voya Investment Management LLC Sells 815,679 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

May 11, 2025
pulisher
May 10, 2025

OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Barclays PLC - MarketBeat

May 10, 2025
pulisher
May 09, 2025

Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright - MarketBeat

May 09, 2025
pulisher
May 09, 2025

Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - The Manila Times

May 09, 2025
pulisher
May 09, 2025

Clinical Laboratory Tests Market Top PlayersARUP - openPR.com

May 09, 2025
pulisher
May 08, 2025

Secondary Hyperparathyroidism Treatment Market Grows with Rising CKD Cases | Amgen, Sanofi, OPKO Health - openPR.com

May 08, 2025
pulisher
May 07, 2025

Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN

May 07, 2025
pulisher
May 04, 2025

Marshall Wace LLP Has $1.36 Million Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

May 04, 2025
pulisher
May 04, 2025

Invesco Ltd. Has $2.29 Million Stake in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

May 04, 2025
pulisher
May 03, 2025

Piper Sandler Keeps Their Buy Rating on Opko Health (OPK) - The Globe and Mail

May 03, 2025
pulisher
May 02, 2025

OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Call Transcript - Insider Monkey

May 02, 2025
pulisher
May 02, 2025

Weekly CEO Buys Highlight - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Labcorp Holdings Inc, BioReference Health, OPKO Health, Inc. - Olean Times Herald

May 02, 2025
pulisher
May 02, 2025

OPKO Health, Inc. (NASDAQ:OPK) Short Interest Update - MarketBeat

May 02, 2025
pulisher
May 01, 2025

OPKO Health’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

May 01, 2025
pulisher
May 01, 2025

OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Quote - OPKO Health, Inc.

May 01, 2025
pulisher
May 01, 2025

OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... By GuruFocus - Investing.com Canada

May 01, 2025
pulisher
May 01, 2025

OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt - simplywall.st

May 01, 2025
pulisher
May 01, 2025

OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

Earnings call transcript: Opko Health misses Q1 2025 earnings forecast By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

OPKO Health Reports Q1 2025 Financial Highlights - TipRanks

May 01, 2025
pulisher
Apr 30, 2025

OPKO Health: Q1 Earnings Snapshot - MySA

Apr 30, 2025
pulisher
Apr 30, 2025

OPKO Health Inc Q1 2025 Earnings: EPS Misses at -$0.10, Revenue Falls Short at $149.9 Million - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Earnings call transcript: Opko Health misses Q1 2025 earnings forecast - Investing.com

Apr 30, 2025
pulisher
Apr 30, 2025

Opko Health earnings missed by $0.01, revenue fell short of estimates - Investing.com

Apr 30, 2025
pulisher
Apr 30, 2025

OPKO Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Apr 30, 2025
pulisher
Apr 30, 2025

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results - GlobeNewswire

Apr 30, 2025
pulisher
Apr 30, 2025

OPKO Health Q1: $225M Oncology Asset Sale to Labcorp Plus New Oral GLP-1 Program Launch - Stock Titan

Apr 30, 2025
pulisher
Apr 30, 2025

OPKO Health (NASDAQ:OPK) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat

Apr 30, 2025
pulisher
Apr 28, 2025

OPKO Health (OPK) to Release Earnings on Wednesday - MarketBeat

Apr 28, 2025
pulisher
Apr 28, 2025

Pediatric Growth Hormone Deficiency Treatment Market Size - openPR.com

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

JP Morgan Initiates Coverage of OPKO Health (OPK) with Neutral Recommendation - MSN

Apr 25, 2025
pulisher
Apr 25, 2025

Analyst Expectations For OPKO Health's Future - Benzinga

Apr 25, 2025
pulisher
Apr 25, 2025

JPMorgan starts Opko Health stock with Neutral rating By Investing.com - Investing.com India

Apr 25, 2025

Opko Health Inc Azioni (OPK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$175.90
price down icon 0.60%
diagnostics_research LH
$250.94
price up icon 2.12%
diagnostics_research WAT
$366.67
price up icon 6.57%
$157.29
price up icon 3.51%
diagnostics_research MTD
$1,174.59
price up icon 8.66%
diagnostics_research IQV
$156.13
price up icon 4.79%
Capitalizzazione:     |  Volume (24 ore):